Curis
CRIS
#10365
Rank
S$23.58 M
Marketcap
S$0.61
Share price
-0.68%
Change (1 day)
-80.83%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -S$42.89 Million

According to Curis's latest financial reports the company's current earnings are S$11.65 Million. In 2024 the company made an earning of -S$55.06 Million, an increase over its 2023 earnings that were of -S$58.43 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$42.89 Million-22.11%
2024 -S$55.06 Million-5.77%
2023 -S$58.43 Million-13.1%
2022 -S$67.24 Million27.52%
2021 -S$52.73 Million65.09%
2020 -S$31.94 Million-9.1%
2019 -S$35.14 Million-4.73%
2018 -S$36.88 Million-41.95%
2017 -S$63.53 Million-14.37%
2016 -S$74.19 Million3.55%
2015 -S$71.64 Million271.52%
2014 -S$19.29 Million76.64%
2013 -S$10.92 Million
2011 -S$9.28 Million27.76%
2010 -S$7.26 Million-43.87%
2009 -S$12.93 Million-23.44%
2008 -S$16.89 Million56.66%
2007 -S$10.78 Million-16.71%
2006 -S$12.95 Million-36.92%
2005 -S$20.52 Million156.25%
2004 -S$8.01 Million-37.24%
2003 -S$12.76 Million-93.34%
2002 -S$0.2 Billion86.79%
2001 -S$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$13.63 B-32,629.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.35 B-29,576.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-S$79.66 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$1.29 B-3,181.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.37 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-S$31.88 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.21 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA